Navigation Links
Spot On Sciences Awarded $1 Million DARPA Grant to Develop a Blood Sample Collection Device
Date:6/25/2012

AUSTIN, Texas, June 25, 2012 /PRNewswire-iReach/ -- Spot On Sciences, Inc., an Austin-based medical device company, has received a two-year, $1 million Small Business Innovation Research (SBIR) Phase II award from the Defense Advanced Research Projects Agency (DARPA) to further develop a device that would allow anyone to take a blood sample in any location and ship or store the samples at room temperature.

The HemaSpot™ device, developed by scientists at Spot On Sciences under a DARPA SBIR Phase I award, is based on dried blood spot (DBS) technology, which is best known for newborn screening.  The patented device allows blood sample collection to be performed away from a lab, improves sample quality, simplifies collection, and allows for stable sample storage for years at room temperature.  Recognizing the potential of the HemaSpot™ device for improving point-of-care diagnostic testing of military personnel, DARPA is supporting further research. 

"We are excited to be working with DARPA to develop a device that is robust enough to allow a soldier in the field to safely collect blood for testing" said Dr. Jeanette Hill, Spot On Sciences' Chief Executive Officer.   "HemaSpot™ has many additional commercial uses for clinical trials, rural and home-bound testing, bio-banking, population studies and a wide range of medical research."

The single-use HemaSpot™ device uses a finger stick to collect and dry two drops of blood within a protective cartridge.  Once dried, the sample is stable at room temperature and can be safely and easily shipped to a diagnostic test site for analysis.  Traditional DBS involves a multi-step process that is subject to errors from moisture, contamination, and sample loss.  HemaSpot's™ innovative design addresses these problems, streamlining the entire process.  Common disease markers can be measured including proteins, nucleic acids and small molecules. 

"Traditional testing by venipuncture draws several vials of blood. HemaSpot™ takes a tiny sample, only two drops, and spreads it onto a filter paper which we have pre-cut into fan blades that can be easily 'plucked' for analysis. They also remain stable at room temperature for years. The real advantage of this technology," continued Dr. Hill, "is that it is much easier and cheaper  to collect and store blood samples. This creates exciting new possibilities for medical research and health care."

About Spot On Sciences

Spot On Sciences, Inc., located in Austin, Texas, is a medical device company that is actively developing innovative methods for collecting and storing biological fluid samples.  The company's current product, HemaSpot™, allows for simplified blood sample collection and storage for dried blood spot (DBS) testing.  More than 20 billion blood tests are performed annually worldwide with in vitro diagnostics showing sales of an estimated US$28.6 billion worldwide.  Spot On Sciences aspires to change existing paradigms in this mature market with technologies that simplify processes, save time and reduce costs.  The firm was selected in 2011 as a finalist for the prestigious Cartier Women's Initiative Award.  For more information visit the company's website at www.spotonsciences.com.

Media Contact: Susan Leininger Spot On Sciences, Inc, 512-836-8012, sueleininger@spotonsciences.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Spot On Sciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Indiana leads U.S. in life sciences jobs and growth
2. Oriel STAT A MATRIX Welcomes New Global Practice Head for Medical Devices and Life Sciences
3. Particle Sciences Expands its cGMP Capabilities with the Addition of Thin Films
4. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
5. USANA Health Sciences Expands Award-Winning Research and Development Team
6. BIOCRATES Life Sciences to Launch Waters Xevo® TQ MS Editions for Two of its Well-established Research Kit Products, AbsoluteIDQ® p180 and p150
7. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
8. Egalet to Present at Life Sciences Europe Conference
9. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
10. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
11. Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
(Date:9/19/2017)... a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed ...   ... Jim Bertolina, ... Tom Tefft ... medical device executive Josh Stopek , PhD, who has led R&D and business development ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... , ... “America On The Brink”: the Christian history of the United States ... creation of published author, William Nowers. Captain Nowers and his wife, Millie, have ... thirty years in the Navy. Following his career as a naval aviator and ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... MD (PRWEB) , ... October 12, 2017 , ... The ... of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual ... – 8. , In honor of Morris F. Collen, a pioneer in the field ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
Breaking Medicine News(10 mins):